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Letters to the Editor
Passive smoking
Sir - I would like to comment on the guest
editorial (Peto & Doll, 1986). The impression given
is that the paper in question (Lee et al., 1986)
attempted to overplay the results of a single case-
control study which happened to find no statistical
significance between passive smoking and lung
cancer. This is not the case. The conclusions 'that
any effect of passive smoke on risk of any of the
major diseases that have been associated with active
smoking is at most small, and may not exist at all'
were not solely dependent on the results from that
study, but were derived 'from all the available
evidence'. Peto and Doll fail to take into account
many of the points made in the paper and also, to
some extent, misrepresent the findings from the
case-control study.
Taking the latter point first, Peto and Doll stated
that the study was based on only 47 married non-
smoking lung cancer patients and gave a relative
risk estimate in relation to spouse smoking of 1.1,
with confidence limits (0.5-2.4) too wide either to
demonstrate any effect or to exclude a substantial
risk. While these results were correctly extracted
from Table II of the paper, they are only part of
the story, since they are based solely on the special
follow-up study of spouses of non-smoking lung
cancer cases and matched controls originally
interviewed in hospital.
They should also have referred to the results
from the original study (relating to ever married
rather than currently married non-smoking lung
cancer cases and based on far more controls). As
shown in Table IV, these data gave a relative risk
estimate for lung cancer in relation to spouse
smoking of 0.8, with an upper 95% confidence limit
of 1.5, noted in the paper to be inconsistent with
some of the larger increases claimed in relation to
passive smoking by other researchers.
Turning to interpretation of the overall evidence
on lung cancer and passive smoking, it is notable
that Peto and Doll make no comment on the
specific weaknesses of many of the published
studies, highlighted both in the paper and in a
recent review (Lee, 1984).
Furthermore, they do not give proper
consideration to the crucial point that 'passive
smoking only results in a relatively small exposure
to the non-smoker' and that there is a substantial
conflict between this small exposure and the
relatively large increase in lung cancer risk claimed
to result from passive smoking.
Peto and Doll accept some conflict, since they
consider that the direct epidemiological evidence on
passive smoking is consistent with an increase in
the lung cancer risk of the order of 20-50%, while
extrapolation, based on risk in active smokers and
the relative exposure of passive and active smokers,
only indicates an increase of the order of 10%, but
they argue this discrepancy is only minor relative to
the various uncertainties involved. While the figure
of 20-50% seems reasonable (a weighted average
relative risk of about 1.3 was cited in the paper),
the estimate of 10% seems far too high.
This 10% estimate is stated to be arrived at by
linear extrapolation using data on urinary cotinine
from a British study (Wald et al., 1984). This study
found that whereas cigarette smokers had a median
urinary cotinine of 1,645ng/ml, non-smokers
exposed to other people's smoke had a cotinine of
6ng/ml, i.e. only 0.36% as high. An extrapolated
estimate of 10% increase in lung cancer risk in non-
smokers would imply about a 25-fold increase in
lung cancer risk in smokers. For women, this
conflicts sharply with the 3-5 fold increase in lung
cancer risk commonly reported in association with
active smoking (Surgeon General, 1982). Put the
other way round, linear extrapolation using relative
urinary cotinine levels would produce a predicted
increase in lung cancer risk in passive smokers of 1
to 2%. Quadratic extrapolation would of course
produce still lower predictions.
In calculating relative doses of passive and active
smokers, estimates based on relative particulate
matter retention give much lower values than those
based on relative cotinine measurements; the
discrepancy between the dosimetry and the
epidemiology then becomes even more obvious.
Passive smokers take in very small amounts of
smoke compared with active smokers and I retain
the view expressed in the paper that 'the marked
increases in risk noted in some studies are more
likely to be a result of bias in the study design than
of a true effect of passive smoking'. The doubt as
to whether the increased risk of lung cancer seen in
non-smoking spouses of smokers is actually a direct
result of passive smoking is also stated in a recent
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IARC Monograph (IARC, 1986) which pointed to
the substantial difficulties in determining passive
smoke exposure and the need for further evidence.
Our paper has produced a range of reactions.
One lesson to be learnt is how important it is to
refer to the original material before forming a
proper judgment about a piece of work.
Yours etc.
P.N. Lee,
Independent Consultant in Statistics,
25 Cedar Road, Sutton,
Surrey SM2 5DG, UK
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Prof. Peto and Sir Richard Doll reply:
Sir - Mr Lee's response to our editorial seems
inappropriate, as we did not discuss the details of
the paper of which he was a co-author (Lee et al.,
1986), and our comments on the interpretation of
his study related solely to inaccurate press coverage
and its exploitation by the tobacco industry. In
relation to the scientific evidence* on passive
smoking, we concluded, in agreement with the
International Agency for Research on Cancer
(1986), that it must be assumed to cause some lung
cancers, but it is impossible to estimate precisely
how many. The evidence, we thought, suggests that
the effect in non-smokers might be to increase the
risk by between about 20% and 50%, which is
consistent with the pooled estimate of about 30%
based on all published studies calculated by Lee et
al. (1986).
There were, however, some differences between
our editorial and the review of the evidence by Lee
et al. (1986). For example, (i) we pointed out that
bias could be in either direction, whereas these
authors mentioned only biases that might increase
the apparent effect of passive smoking; (ii) we
observed that chemical and physical differences
between mainstream and sidestream smoke would
make it impossible to predict the effect of passive
smoking from measurements of, for example,
urinary cotinine even if the form of the dose-
response at very low doses were known; and (iii) we
concluded that the evidence that passive smoking
confers an appreciable risk, although inconclusive,
is suggestive enough to justify concern.
Mr Lee has in his letter consistently selected data
that minimise the predicted risk. He cites the
relative risk of 0.8 from one of several analyses in
Lee et al. (1986), when it might equally cogently be
argued that the relative risk of 1.3 based on cases
whose spouses were interviewed is a more reliable
estimate; he quotes the median urinary cotinine
(6ngm1-1) from a study of non-smokers passively
exposed to smoke (Wald et al., 1984) rather than
the mean, which was over 1Ingml-1; he quotes a
3-5 fold increase in lung cancer rates in women
smokers, ignoring evidence that this observed risk is
probably a serious underestimate of the effect of
lifelong smoking in women (Doll et al., 1980); and
he selects particulate retention as a useful index of
exposure in passive smokers, giving a still lower
predicted effect, although there is no evidence that
this is a more appropriate measure of carcinogenic
risk than urinary cotinine.
The most surprising aspect of Mr Lee's letter,
however, is that it should have been addressed to
us at all. The differences between his interpretation
of the evidence and ours are of emphasis rather
than fact, and our principal concern was to draw
attention to the inaccuracy of The Times' report of
his work which was circulated to all MP's by the
Tobacco Advisory Council. We presume that Mr
Lee has privately drawn the Council's attention to
the major factual errors in The Times' report.
Yours etc.
J. Peto,
Section of Epidemiology,
Institute of Cancer Research,
Sutton, Surrey SM2 5PX, UK
and
R. Doll,
Imperial Cancer Research Fund,
Cancer Epidemiology Unit,
Radcliffe Infirmary,
Oxford OX2 6HE, UK.